GBA Presents: RADIO SAVANT-!

Discussion in 'Stocks' started by stonedinvestor, May 13, 2022.

  1. vanzandt

    vanzandt

    PYPL.... $71.43
    Watch out below.

    >>>Sophomore Master Class 801: Sector Rotation
     
    #17351     May 3, 2023
    TrailerParkTed likes this.
  2. vanzandt

    vanzandt

    This one covers two of my classes I think.

    $34--> $28 (-17.7%)

    -Sophomore Master Stock Player: "Never Reach Out For the Falling Knife"
    -Junior English Lit Class : The Financial Ramifications of Steering Internet Readers Wrong and Your Career"
     
    #17352     May 3, 2023
  3. In giving voice to the digital ghosts of the deceased, chatbots are trying to succeed where photography and dreams fail.


    [​IMG]


    • Maybe this AI is not all we thought it would be.
     
    #17353     May 4, 2023
  4. What is Vontier.-

    Vontier reports Q1 adjusted EPS 68c, consensus 61c 06:22 VNT

    Vontier raises Fy23 adjusted EPS view to $2.77-$2.87 from $2.73-$2.83 06:24 VNT


    Description

    Vontier Corporation engages in the research and development, manufacture, sale, and distribution of technical equipment, components, software, and services for manufacturing, repairing, and servicing in the mobility ecosystem worldwide. The company offers a range of solutions, including environmental sensors; fueling equipment; field payment hardware; point-of sale, workflow, and monitoring software; vehicle tracking and fleet management; software solutions for traffic light control; and vehicle mechanics', and technicians' equipment. It operates through two segments: Mobility Technologies, and Diagnostics and Repair Technologies. The Mobility Technologies segment products include solutions and services in the areas of environmental compliance, fuel dispensing, remote fuel management, point-of-sale and payment systems, vehicle tracking and fleet management, and traffic management products marketed under the Gilbarco, Veeder-Root, Orpak, DRB, Teletrac Navman, and Global Traffic Technologies brands. The Diagnostics and Repair Technologies segment products comprise vehicle repair tools, toolboxes, automotive diagnostic equipment, and software, as well as wheel-service equipment for automotive tire installation and repair shops, including brake lathes, tire changers, wheel balancers, wheel aligners, lifts, and inspection lane systems under the Matco and Coats brands. The company markets its products and services to retail and commercial fueling operators, convenience store and in-bay car wash operators, tunnel car wash and commercial vehicle repair businesses, municipal governments, and public safety entities and fleet owners/operators through a network of franchised mobile distributors, as well as direct sales personnel and independent distributors. It serves customers in North America, the Asia Pacific, Europe, and Latin America. The company was incorporated in 2019 and is headquartered in Raleigh, North Carolina.
     
    #17354     May 4, 2023
  5. --Confluent price target lowered to $31 from $33 at JMP Securities 06:43 CFLT

    Parson's update-- I only managed to get this stk into one of my accounts before earnings.
    That's my F up... I was using some bad experiences with Leidos LDOS as my guide instead of following my research on contracts which I laid out here.

    Several HF's have told me they did buy! That pisses me off even more.... Up $2+ yesterday/
    I would like to put this idea into more accounts-

    Parsons price target raised to $53 from $50 at Baird » 06:36 PSN
     
    #17355     May 4, 2023
  6. What a monster I gave you all! :sneaky:

    SiteOne Landscape price target raised to $170 from $163 at Baird » 06:38 SITE
     
    #17356     May 4, 2023
  7. What is Enovis?

    Enovis reports Q1 adjusted EPS 44c, consensus 37c » 06:12 ENOV

    Enovis raises 2023 adjusted EPS view to $2.18-$2.32 from $2.15-$2.30 » 06:14 ENOV


    Description
    Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufacture and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. En
     
    #17357     May 4, 2023
  8. Remember that huge option trade on Paramount earn>? I think that dude lost everything!

    Paramount reports Q1 EPS 9c, consensus 17c 07:16 PARA
     
    #17358     May 4, 2023
  9. I don't want to make a snap judgement but could this be the bottom for Peloton?

    Peloton sees Q4 revenue $630M-$650M, consensus $607.65M 07:18 PTON

    I'm not familiar with the metrics here-- this sounds good--

    Peloton reports 6.7M members at end of Q3 07:14 PTON
     
    #17359     May 4, 2023
  10. --Sally Beauty reports Q2 adjusted EPS 41c, consensus 37c 07:18 SBH

    --XPO Logistics reports Q1 adjusted EPS 56c, consensus 46c 06:16 XPO


    IDEA OF THE DAY-AI drug creation company-?

    Absci initiated with a Buy at H.C. Wainwright 06:16 ABSI- AI & Bio

    Description

    Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington.
     
    #17360     May 4, 2023